Compare
5 stocks, side by sideRelative performance · rebased to 100
RLAYDNLIRCUSACADNAMS
| RLAYRelay Therapeutics, Inc. | DNLIDenali Therapeutics Inc. | RCUSArcus Biosciences, Inc. | ACADACADIA Pharmaceuticals Inc. | NAMSNewAmsterdam Pharma Company N.V. | |
|---|---|---|---|---|---|
| Smart Score | 9/10 | 9/10 | 8/10 | 9/10 | 3/10 |
| Price | $17.83 | $24.73 | $30.25 | $23.72 | $31.73 |
| 1 month | +26% | +28% | +25% | +12% | -12% |
| 1 year | +439% | +72% | +246% | +5.8% | +72% |
| 5 year | -49% | -67% | +27% | -8.2% | +225% |
| P/E (TTM) | -14.2 | -7.7 | -10.3 | 10.8 | -17.4 |
| P/E vs sector | - | - | - | -66% | - |
| Market cap | $3.9B | $3.9B | $3.8B | $4.1B | $3.7B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.